Jocil Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 10, 2025, 9:19 pm

Competitors of Jocil Ltd

All Competitor Stocks of Jocil Ltd

Quarterly Result

Last Updated: August 20, 2025, 8:30 am

Below is a detailed analysis of the quarterly data for Jocil Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 269.94 Cr.. The value appears strong and on an upward trend. It has increased from 178.15 Cr. (Mar 2025) to 269.94 Cr., marking an increase of 91.79 Cr..
• For Expenses, as of Jun 2025, the value is 266.18 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 176.76 Cr. (Mar 2025) to 266.18 Cr., marking an increase of 89.42 Cr..
• For Operating Profit, as of Jun 2025, the value is 3.76 Cr.. The value appears strong and on an upward trend. It has increased from 1.39 Cr. (Mar 2025) to 3.76 Cr., marking an increase of 2.37 Cr..
• For OPM %, as of Jun 2025, the value is 1.39%. The value appears strong and on an upward trend. It has increased from 0.78% (Mar 2025) to 1.39%, marking an increase of 0.61%.
• For Other Income, as of Jun 2025, the value is 0.49 Cr.. The value appears to be declining and may need further review. It has decreased from 0.68 Cr. (Mar 2025) to 0.49 Cr., marking a decrease of 0.19 Cr..
• For Interest, as of Jun 2025, the value is 0.06 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.06 Cr..
• For Depreciation, as of Jun 2025, the value is 1.22 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.42 Cr. (Mar 2025) to 1.22 Cr., marking a decrease of 0.20 Cr..
• For Profit before tax, as of Jun 2025, the value is 2.97 Cr.. The value appears strong and on an upward trend. It has increased from 0.59 Cr. (Mar 2025) to 2.97 Cr., marking an increase of 2.38 Cr..
• For Tax %, as of Jun 2025, the value is 25.25%. The value appears to be increasing, which may not be favorable. It has increased from 22.03% (Mar 2025) to 25.25%, marking an increase of 3.22%.
• For Net Profit, as of Jun 2025, the value is 2.22 Cr.. The value appears strong and on an upward trend. It has increased from 0.45 Cr. (Mar 2025) to 2.22 Cr., marking an increase of 1.77 Cr..
• For EPS in Rs, as of Jun 2025, the value is 2.50. The value appears strong and on an upward trend. It has increased from 0.51 (Mar 2025) to 2.50, marking an increase of 1.99.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 5:03 am

Growth

Last Updated: September 5, 2025, 8:25 am

Balance Sheet

Last Updated: November 9, 2025, 2:19 pm

Below is a detailed analysis of the balance sheet data for Jocil Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 9.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 9.00 Cr..
• For Reserves, as of Sep 2025, the value is 201.00 Cr.. The value appears strong and on an upward trend. It has increased from 197.00 Cr. (Mar 2025) to 201.00 Cr., marking an increase of 4.00 Cr..
• For Borrowings, as of Sep 2025, the value is 5.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 0.00 Cr. (Mar 2025) to 5.00 Cr., marking an increase of 5.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 74.00 Cr.. The value appears to be improving (decreasing). It has decreased from 82.00 Cr. (Mar 2025) to 74.00 Cr., marking a decrease of 8.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 290.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 288.00 Cr. (Mar 2025) to 290.00 Cr., marking an increase of 2.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 35.00 Cr.. The value appears to be declining and may need further review. It has decreased from 37.00 Cr. (Mar 2025) to 35.00 Cr., marking a decrease of 2.00 Cr..
• For CWIP, as of Sep 2025, the value is 9.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Mar 2025) to 9.00 Cr., marking an increase of 1.00 Cr..
• For Investments, as of Sep 2025, the value is 14.00 Cr.. The value appears to be declining and may need further review. It has decreased from 30.00 Cr. (Mar 2025) to 14.00 Cr., marking a decrease of 16.00 Cr..
• For Other Assets, as of Sep 2025, the value is 232.00 Cr.. The value appears strong and on an upward trend. It has increased from 212.00 Cr. (Mar 2025) to 232.00 Cr., marking an increase of 20.00 Cr..
• For Total Assets, as of Sep 2025, the value is 290.00 Cr.. The value appears strong and on an upward trend. It has increased from 288.00 Cr. (Mar 2025) to 290.00 Cr., marking an increase of 2.00 Cr..

Notably, the Reserves (201.00 Cr.) exceed the Borrowings (5.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Jocil Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 1.15. This value is below the healthy minimum of 5. It has decreased from 1.94 (Mar 24) to 1.15, marking a decrease of 0.79.
• For Diluted EPS (Rs.), as of Mar 25, the value is 1.15. This value is below the healthy minimum of 5. It has decreased from 1.94 (Mar 24) to 1.15, marking a decrease of 0.79.
• For Cash EPS (Rs.), as of Mar 25, the value is 7.53. This value is within the healthy range. It has decreased from 8.81 (Mar 24) to 7.53, marking a decrease of 1.28.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 232.03. It has decreased from 237.10 (Mar 24) to 232.03, marking a decrease of 5.07.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 232.03. It has decreased from 237.10 (Mar 24) to 232.03, marking a decrease of 5.07.
• For Dividend / Share (Rs.), as of Mar 25, the value is 0.50. This value is below the healthy minimum of 1. It has decreased from 1.50 (Mar 24) to 0.50, marking a decrease of 1.00.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 974.53. It has increased from 848.04 (Mar 24) to 974.53, marking an increase of 126.49.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 8.15. This value is within the healthy range. It has decreased from 10.22 (Mar 24) to 8.15, marking a decrease of 2.07.
• For PBIT / Share (Rs.), as of Mar 25, the value is 1.77. This value is within the healthy range. It has decreased from 3.35 (Mar 24) to 1.77, marking a decrease of 1.58.
• For PBT / Share (Rs.), as of Mar 25, the value is 1.51. This value is within the healthy range. It has decreased from 2.98 (Mar 24) to 1.51, marking a decrease of 1.47.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 1.15. This value is below the healthy minimum of 2. It has decreased from 1.94 (Mar 24) to 1.15, marking a decrease of 0.79.
• For PBDIT Margin (%), as of Mar 25, the value is 0.83. This value is below the healthy minimum of 10. It has decreased from 1.20 (Mar 24) to 0.83, marking a decrease of 0.37.
• For PBIT Margin (%), as of Mar 25, the value is 0.18. This value is below the healthy minimum of 10. It has decreased from 0.39 (Mar 24) to 0.18, marking a decrease of 0.21.
• For PBT Margin (%), as of Mar 25, the value is 0.15. This value is below the healthy minimum of 10. It has decreased from 0.35 (Mar 24) to 0.15, marking a decrease of 0.20.
• For Net Profit Margin (%), as of Mar 25, the value is 0.11. This value is below the healthy minimum of 5. It has decreased from 0.22 (Mar 24) to 0.11, marking a decrease of 0.11.
• For Return on Networth / Equity (%), as of Mar 25, the value is 0.49. This value is below the healthy minimum of 15. It has decreased from 0.82 (Mar 24) to 0.49, marking a decrease of 0.33.
• For Return on Capital Employeed (%), as of Mar 25, the value is 0.75. This value is below the healthy minimum of 10. It has decreased from 1.39 (Mar 24) to 0.75, marking a decrease of 0.64.
• For Return On Assets (%), as of Mar 25, the value is 0.35. This value is below the healthy minimum of 5. It has decreased from 0.61 (Mar 24) to 0.35, marking a decrease of 0.26.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. It has decreased from 0.02 (Mar 24) to 0.00, marking a decrease of 0.02.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 3.06. It has increased from 2.83 (Mar 24) to 3.06, marking an increase of 0.23.
• For Current Ratio (X), as of Mar 25, the value is 2.99. This value is within the healthy range. It has decreased from 3.48 (Mar 24) to 2.99, marking a decrease of 0.49.
• For Quick Ratio (X), as of Mar 25, the value is 1.35. This value is within the healthy range. It has decreased from 2.02 (Mar 24) to 1.35, marking a decrease of 0.67.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.20. This value is within the healthy range. It has decreased from 6.80 (Mar 24) to 6.20, marking a decrease of 0.60.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 128.54 (Mar 24) to 0.00, marking a decrease of 128.54.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 28.35 (Mar 24) to 0.00, marking a decrease of 28.35.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has increased from -28.54 (Mar 24) to 0.00, marking an increase of 28.54.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 71.65 (Mar 24) to 0.00, marking a decrease of 71.65.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 31.18. This value is within the healthy range. It has increased from 27.47 (Mar 24) to 31.18, marking an increase of 3.71.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 5.39. This value is within the healthy range. It has decreased from 6.23 (Mar 24) to 5.39, marking a decrease of 0.84.
• For Enterprise Value (Cr.), as of Mar 25, the value is 97.29. It has decreased from 129.34 (Mar 24) to 97.29, marking a decrease of 32.05.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.11. This value is below the healthy minimum of 1. It has decreased from 0.17 (Mar 24) to 0.11, marking a decrease of 0.06.
• For EV / EBITDA (X), as of Mar 25, the value is 13.43. This value is within the healthy range. It has decreased from 14.25 (Mar 24) to 13.43, marking a decrease of 0.82.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.14. This value is below the healthy minimum of 1. It has decreased from 0.19 (Mar 24) to 0.14, marking a decrease of 0.05.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has increased from -28.54 (Mar 24) to 0.00, marking an increase of 28.54.
• For Price / BV (X), as of Mar 25, the value is 0.59. This value is below the healthy minimum of 1. It has decreased from 0.71 (Mar 24) to 0.59, marking a decrease of 0.12.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.14. This value is below the healthy minimum of 1. It has decreased from 0.19 (Mar 24) to 0.14, marking a decrease of 0.05.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness